Literature DB >> 7860906

Quantification of coronary artery calcium by electron beam computed tomography for determination of severity of angiographic coronary artery disease in younger patients.

R B Kaufmann1, P A Peyser, P F Sheedy, J A Rumberger, R S Schwartz.   

Abstract

OBJECTIVES: This study attempted to 1) evaluate five quantitative measures of coronary artery calcium and determine which best agreed with coronary artery disease severity at angiography; and 2) determine optimal quantity cutpoints to distinguish among no, mild and significant disease.
BACKGROUND: Coronary artery calcium identified noninvasively by electron beam computed tomography is a sensitive marker for atherosclerosis. Quantitative assessments of calcium could distinguish among patients with no, mild and significant disease in clinical, screening and research settings.
METHODS: One hundred sixty patients, 23 to 59 years old, underwent coronary angiography and electron beam computed tomography. Coronary artery calcium was defined as dense (> 130 Hounsfield units) foci > or = 2 mm2 on the tomogram. Regression and receiver operating characteristic analyses were used to evaluate five quantitative measures of calcium as predictors of the largest stenosis in the coronary arteries and to identify optimal cutpoints for distinguishing among disease categories. No disease was defined as no stenosis, mild disease as 10% to 49% diameter stenosis in one or more major branches and significant disease as > or = 50% diameter stenosis in one or more major branches.
RESULTS: All measures evaluated performed well. With calcific area as the quantitative measure, the best cutpoint for discriminating between patients with and without disease was the presence of calcium: sensitivity 81%, specificity 86% and overall accuracy 83%. The best cutpoint for discriminating between patients with and without significant disease was 18 mm2: sensitivity 86%, specificity 81% and accuracy 83%.
CONCLUSIONS: Because the ranges of calcium quantity overlapped across disease categories, no cutpoints would distinguish among categories with absolute certainty. However, selected cutpoints could rule out disease in most healthy subjects and identify most patients with significant disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7860906     DOI: 10.1016/0735-1097(94)00435-S

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

1.  Reproducibility of two coronary calcium quantification algorithms in patients with different degrees of calcification.

Authors:  S Möhlenkamp; T R Behrenbeck; H Pump; P Kriener; S Lange; D Baumgart; R M Seibel; D H Grönemeyer; R Erbel
Journal:  Int J Cardiovasc Imaging       Date:  2001-04       Impact factor: 2.357

Review 2.  Update on using coronary calcium screening by computed tomography to measure risk for coronary heart disease.

Authors:  Brad H Thompson; William Stanford
Journal:  Int J Cardiovasc Imaging       Date:  2005-02       Impact factor: 2.357

3.  Relationship between baseline coronary calcium score and demonstration of coronary artery stenoses during follow-up MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Boaz D Rosen; Veronica Fernandes; Robyn L McClelland; Jeffrey J Carr; Robert Detrano; David A Bluemke; João A C Lima
Journal:  JACC Cardiovasc Imaging       Date:  2009-10

Review 4.  Coronary computed tomographic angiography (CCTA) in community hospitals: "current and emerging role".

Authors:  Rakesh K Sharma; Donald J Voelker; Rajiv K Sharma; Vibhuti N Singh; Girish Bhatt; Mathilde Moazazi; Teresa Nash; Hanumanth K Reddy
Journal:  Vasc Health Risk Manag       Date:  2010-05-25

Review 5.  Cardiac risk stratification: role of the coronary calcium score.

Authors:  Rakesh K Sharma; Rajiv K Sharma; Donald J Voelker; Vibhuti N Singh; Deepak Pahuja; Teresa Nash; Hanumanth K Reddy
Journal:  Vasc Health Risk Manag       Date:  2010-08-09

6.  Clinical Role of Hybrid Imaging.

Authors:  Edward M Hsiao; Bilal Ali; Sharmila Dorbala
Journal:  Curr Cardiovasc Imaging Rep       Date:  2010-07-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.